Form 4 for EVMN Evommune, Inc.
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0001757072-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-12 | 2025-11-07 | EVMN | Carver Kyle | CFO | C - Cnv Deriv | — | +3,175 | 75.8K | +4% | — |
| D | 2025-11-12 | 2025-11-07 | EVMN | Carver Kyle | CFO | C - Cnv Deriv | — | -25.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-07 | C | A | 3,175 | — | 75,800 | D | — | — | (F1) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date. |
| 2 | Derivative | Series B Preferred Stock | 2025-11-07 | C | D | 25,000 | — | 0 | D | — · — to — | 3,175 Common Stock | (F1) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date. |